Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoplasm Metastasis × tebentafusp × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 6 Melanoma 5 Select Advanced Solid Tumors 1 Sarcoma, Clear Cell 1 Sarcoma 1 Nevus, Blue 1 Neoplasm Metastasis 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Advanced or Metastatic Solid Tumors 1

Interventions

pembrolizumab 154 Gemcitabine 139 Capecitabine 121 Paclitaxel 118 Fluorouracil 116 Oxaliplatin 110 Bevacizumab 104 Leucovorin 97 Nivolumab 96 Docetaxel 92 Cisplatin 89 Irinotecan 87 Carboplatin 84 Radiosurgery 83 Cyclophosphamide 70 Cetuximab 70 Magnetic Resonance Spectroscopy 67 Trastuzumab 56 Biopsy 56 Radiotherapy 55 Specimen Handling 54 Ipilimumab 50 Everolimus 48 Pemetrexed 45 Drug Therapy 45 Albumin-Bound Paclitaxel 44 130-nm albumin-bound paclitaxel 43 Doxorubicin 41 aldesleukin 37 Fulvestrant 37

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07057596 2026-03-06

NEO-TB

Grupo Español Multidisciplinar de Melanoma

Phase 2 Recruiting

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡